Evaluating Medrol Dose Pack for treating headaches after concussions
Official title: Assessment of the Efficacy of Medrol Dose Pack for Post-Concussive Headaches
Run by Northwell Health · NCT04685772 · Data updated 2026-11-12
This study is testing if a medication called Medrol can help people with headaches after a concussion feel better and get back to their normal activities faster.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | Northwell Health Academic / other |
| Locations | 1 site (Manhasset, New York) |
| Status | Recruiting |
| Started | April 1, 2021 |
| Main results expected | December 1, 2027 |
| Study ends | December 1, 2027 |
| Registry record updated | August 26, 2026 |
| Trial ID | NCT04685772 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old who experience daily headaches of significant severity following a concussion.
✕Probably not a fit
Patients with known intracranial hemorrhage or those whose headaches do not meet the study criteria may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the effectiveness of corticosteroids, specifically the Medrol Dose Pack, in reducing the frequency and intensity of acute post-concussive headaches. The investigators hypothesize that corticosteroid treatment will not only alleviate headaches but also decrease other related symptoms, facilitating a quicker return to normal activities such as school, work, or sports. The study is novel as it focuses on individuals suffering from post-concussion headaches, a condition that currently lacks established treatment guidelines. Participants will be monitored for their response to the medication over a specified period.
Why it matters
Potential benefit: If successful, this study could provide a new treatment option for patients suffering from debilitating post-concussive headaches.
How similar studies have gone: While corticosteroids have been studied in severe traumatic brain injury, this specific approach for post-concussive headaches is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Provision of signed and dated informed consent form (in person or via telehealth) 2. Stated willingness to comply with all study procedures and availability for the duration of the study 3. Male or female, aged \>18 years old 4. Ability to take oral medication and be willing to adhere to the study regimen as described in this protocol 5. Patients presenting with all types of post-concussive headache with \>5/10 in severity on the numerical analog scale. 6. Headache that occurs for \> 4 hours per day 7. Headache that occurs every day 8. Headache that began after concussion, patient was diagnosed at an outpatient clinic or was hospitalized 9. Headache developed within 7 days post-injury and patient presenting within 30 days from initial trauma 10. A diagnosis of concussion. 11. If a patient is taking another pain medication, this still be included in the stud Exclusion Criteria: 1. Any evidence of known intracranial hemorrhage on neuroimaging 2. Headache developing after 7 days post injury and patient presenting after 30 days from initial trauma 3. Headache occurs \< 4 hours per day 4. Headache does not occur daily 5. Age \< or = 18 6. Headache is \< 5 in severity on numerical analog scale 7. Presence of increase in intracranial pressure or papilledema 8. Any contraindication to corticosteroids 9. Allergy or sensitivity to corticosteroids 10. Active Tuberculosis 11. Active pregnancy 12. Currently on corticosteroids for another reason 13. Participants with fungal infection
Where it's running
-
Northwell Health - North Shore University Hospital
Manhasset, New York, United States Recruiting
Study contacts
- Principal investigator: Jamie S Ullman, MD — Hofstra Northwell School of Medicine
- Study coordinator: Jamie Ullman, MD
- Email: Jullman1@northwell.edu
- Phone: (516) 562 4300
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Personalized brain stimulation for long-term symptoms after concussion
This study will try personalized, noninvasive brain stimulation (TMS) to reduce dizziness, headaches, memory problems, and other lasting symptoms in adults aged 18–65 after a concussion.
-
HEADS Registry: Headache, Ear, Auditory, Dizziness, and Sinus</n> Registry
This registry tests whether collecting online symptom reports from adults in the U.S. with sinus, vestibular, ear, or headache symptoms can help improve diagnosis and treatment.
-
Immediate neck manual therapy effects on atlas position and neck muscles
This trial tests two upper neck manual therapy techniques to see their immediate effect on neck alignment, atlas position, and a neck muscle shape in adults with head and neck pain or headaches.
-
Vitamin IV lidocaine before fundal pressure to prevent headache after cesarean using spinal anesthesia
This trial tests whether a single intravenous dose of lidocaine given before fundal pressure during cesarean delivery reduces the chance or severity of headache.
-
Muscle Position and Dry Needling Efficacy
This study tests whether the position of the upper trapezius during dry needling changes pain and function for people with chronic neck pain.
-
GyroStim SMART rotational therapy for post-concussion syndrome
This project will test whether adding GyroStim sensorimotor multi-axis rotational therapy (SMART) helps adults with persistent post-concussion syndrome recover faster and more fully.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.